With the recent spread of this
COVID-19 pandemic, the availability and facility of testing was a dreadful
question. However, in a recent series of events, the GOI approved about 98
firms to supply PCR kits for testing the coronavirus on symptomatic or asymptomatic
patients.
How fast the test is done is one of
the important factors in the efficient management of an outbreak. Knowing that
the patient has coronavirus implies the health care workers know how to react,
the type of treatment should be given, the place where the patient should be
kept in the hospital specifically in those communities having dedicated
COVID-19 ward.
Today, the most dependable test for
detection of coronavirus is testing to confirm the presence of virus RNA.
This is the reason real-time reverse
transcription –Polymerase Chain Reaction (RT-PCR) depending tests are mostly
recommended for diagnosis of COVID-19. This test detects the presence of the
virus RNA in the human samples. It is a process where some copies of DNA are
subjected to amplification for production of several millions of copies.
Moreover, the test also requires primers, nucleotides, enzyme cofactors, probes
and a buffer solution.
Labs across the world are making use
of primers and probes for testing the presence of COVID 19 virus.
This is the reason India has also
approved the use of PCR kits for speeding the test of Covid-19. The Indian
Council of Medical Research(ICMR) has approved 176 labs along with 47 private
labs for the conductance of tests. The first test kit that obtains FDA approval
is the Cobas SARS CoV-2 kit from Roche, has also got approval in India. Then
the second one Taq path COVID 19 combi PCR kit from Thermo Fisher also got
validation from ICMR labs. All newly developed and imported kits have to abide by
the medical device regulations in India. However, the stringent clauses have been eased at the
moment.
Moreover, ICMR has also validated
kits from three Indian manufacturers. These agencies will offer the primer and
probes along with the master mix to the selected government labs, but it is not
clear whether they are exactly the similar probes and primers as per CDC
protocol.
As of advisory from ICMR on May 26,
the use of FDA approved kits along with the primers and probes is advisable for
private labs. When proper certification along with training is in place, all
accredited labs can give the required results.
Comments
Post a Comment
Please do not enter any spam link in the comment box